Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
The first “antisense” drug to be tested in chronic lymphocytic leukemia (CLL) shows benefit in a phase III clinical trial for a specific subset of patients – those who are still sensitive to a chemotherapy drug often used to treat this cancer.
A featured paper in the Feb. 14 issue of Nature Cancer Gene Therapy demonstrates that cancer cells in the liver are excellent targets for gene therapy using adenoviral vectors, based upon a fundamental new understanding of the differences between cancerous and normal liver cells. The findings signal a new way to treat cancers that have spread to the liver, such as metastatic cancers of the colon and breast.
Johns Hopkins cardiologists are calling for an expansion of the criteria widely used by physicians to detect and assess a postmenopausal woman’s chances of developing cardiovascular disease, the leading cause of death among women in the United States.
Federal legislation aimed at fighting the No. 1 killer of American women — heart disease, stroke and other cardiovascular diseases — today received the endorsement of several leading women’s heart and health care organizations.
Researchers have developed a more accurate way to predict the risk of developing cardiovascular disease among women, according to a study in the February 14 issue of JAMA.
AstraZeneca has pledged USD$10 million to help fund 50 new American Cancer Society Patient Navigator Program sites over the next five years in communities throughout the United States. The Patient Navigator Program is an initiative to assist individual cancer patients in negotiating the health care system.
The Australian Parliamentary Secretary to the Treasurer, Chris Pearce, today warned about the dangers associated with wearing non-prescription cosmetic contact lenses.
There is no convincing evidence that taking omega-3 fatty acids on their own can alleviate depression, says Drug and Therapeutics Bulletin (DTB).
Doctors are still denying older people the sorts of tests and treatment they would offer to younger patients, reveals a survey in Quality and Safety in Health Care.